PVI
Pura Vida Investments Portfolio holdings
AUM
$16.6M
This Quarter Return
-8.32%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$629M
AUM Growth
+$629M
(-24%)
Cap. Flow
+$22.6M
Cap. Flow
% of AUM
3.6%
Top 10 Holdings %
Top 10 Hldgs %
47.7%
Holding
242
New
26
Increased
27
Reduced
24
Closed
38
Top Buys
| 1 |
Glaukos
GKOS
|
$36.2M |
| 2 |
Guardant Health
GH
|
$16.2M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
$13.9M |
| 4 |
Lyra Therapeutics
LYRA
|
$11.6M |
| 5 |
Pulmonx
LUNG
|
$10.9M |
Top Sells
| 1 |
Vertex Pharmaceuticals
VRTX
|
$19M |
| 2 |
C4 Therapeutics
CCCC
|
$15.2M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$13.5M |
| 4 |
ICU Medical
ICUI
|
$12.8M |
| 5 |
CNVY
Convey Health Solutions Holdings, Inc.
CNVY
|
$11.3M |
Sector Composition
| 1 | Healthcare | 90.17% |
| 2 | Industrials | 0.83% |
| 3 | Consumer Staples | 0.74% |
| 4 | Materials | 0.31% |
| 5 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SNCE
51
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
| $2.22M | 0.13% |
55,320
+5,000
| +10% | +$201K |
|
|
NYXH
52
Nyxoah
NYXH
$221M
| $2.19M | 0.13% |
221,949
| – | – |
|
53
Insulet
PODD
$24.2B
| $2.18M | 0.13% |
+10,000
| New | +$2.18M |
|
54
Cogent Biosciences
COGT
$1.83B
| $2.15M | 0.13% |
+238,787
| New | +$2.15M |
|
55
Natera
NTRA
$23B
| $2.13M | 0.12% |
+60,159
| New | +$2.13M |
|
56
Arcutis Biotherapeutics
ARQT
$1.91B
| $2.13M | 0.12% |
100,000
-89,363
| -47% | -$1.9M |
|
57
Alpha Teknova
TKNO
$227M
| $2.11M | 0.12% |
251,112
| – | – |
|
58
GH Research
GHRS
$870M
| $2.08M | 0.12% |
208,527
| – | – |
|
59
Edwards Lifesciences
EW
$47.7B
| $1.97M | 0.11% |
+20,700
| New | +$1.97M |
|
|
AMRS
60
DELISTED
Amyris Inc.
AMRS
| $1.94M | 0.11% |
1,050,399
-1,411,037
| -57% | -$2.61M |
|
|
AVDL
61
Avadel Pharmaceuticals
AVDL
$1.45B
| $1.93M | 0.11% |
+789,181
| New | +$1.93M |
|
|
SONX
62
DELISTED
Sonendo, Inc.
SONX
| $1.76M | 0.1% |
1,023,424
| – | – |
|
|
QTNT
63
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $1.6M | 0.09% |
166,550
-87,385
| -34% | -$839K |
|
64
Exelixis
EXEL
$9.95B
| $1.56M | 0.09% |
+75,000
| New | +$1.56M |
|
|
APEN
65
DELISTED
Apollo Endosurgery, Inc.
APEN
| $1.56M | 0.09% |
427,057
| – | – |
|
66
Standard BioTools
LAB
$493M
| $1.36M | 0.08% |
850,000
| – | – |
|
67
Esperion Therapeutics
ESPR
$490M
| $1.35M | 0.08% |
+212,123
| New | +$1.35M |
|
68
Schrodinger
SDGR
$1.42B
| $1.32M | 0.08% |
50,000
| – | – |
|
|
LHDX
69
DELISTED
Lucira Health, Inc. Common Stock
LHDX
| $1.29M | 0.07% |
690,663
+3,450
| +0.5% | +$6.42K |
|
70
Viridian Therapeutics
VRDN
$1.59B
| $1.22M | 0.07% |
105,460
| – | – |
|
71
Xenon Pharmaceuticals
XENE
$2.99B
| $1.22M | 0.07% |
40,002
+25,000
| +167% | +$761K |
|
72
Adaptive Biotechnologies
ADPT
$1.96B
| $1.21M | 0.07% |
150,000
| – | – |
|
73
Verastem
VSTM
$585M
| $1.17M | 0.07% |
+83,689
| New | +$1.17M |
|
|
BLU
74
DELISTED
BELLUS Health Inc.
BLU
| $1.13M | 0.07% |
122,000
-268,097
| -69% | -$2.48M |
|
|
MDVL
75
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
| $1.09M | 0.06% |
14,282
| – | – |
|